際際滷shows by User: pharmaknowledge / http://www.slideshare.net/images/logo.gif 際際滷shows by User: pharmaknowledge / Mon, 07 May 2012 16:28:33 GMT 際際滷Share feed for 際際滷shows by User: pharmaknowledge Spotlight On... Anti-Thrombotics, A Review of Jan-Mar 2011-- Pharma Matters Report /pharmaknowledge/spotlight-on-cwpenissue03 spotlightoncwpenissue03-120507162836-phpapp01
The thrombosis market is poised to change dramatically. The possibility of engineering a replacement for warfarin, or a side-effect free oral anticoagulant suitable for chronic thrombosis prevention has presented an attractive opportunity for the pharma industry, and a raft of new products are now entering the market. ]]>
The thrombosis market is poised to change dramatically. The possibility of engineering a replacement for warfarin, or a side-effect free oral anticoagulant suitable for chronic thrombosis prevention has presented an attractive opportunity for the pharma industry, and a raft of new products are now entering the market. ]]> Mon, 07 May 2012 16:28:33 GMT /pharmaknowledge/spotlight-on-cwpenissue03 pharmaknowledge@slideshare.net(pharmaknowledge) Spotlight On... Anti-Thrombotics, A Review of Jan-Mar 2011-- Pharma Matters Report pharmaknowledge The thrombosis market is poised to change dramatically. The possibility of engineering a replacement for warfarin, or a side-effect free oral anticoagulant suitable for chronic thrombosis prevention has presented an attractive opportunity for the pharma industry, and a raft of new products are now entering the market. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/spotlightoncwpenissue03-120507162836-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The thrombosis market is poised to change dramatically. The possibility of engineering a replacement for warfarin, or a side-effect free oral anticoagulant suitable for chronic thrombosis prevention has presented an attractive opportunity for the pharma industry, and a raft of new products are now entering the market.
Spotlight On... Anti-Thrombotics, A Review of Jan-Mar 2011-- Pharma Matters Report from Thomson Reuters
]]> 1041 5 https://cdn.slidesharecdn.com/ss_thumbnails/spotlightoncwpenissue03-120507162836-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 The Ones to Watch, Oct. - Dec. 2009 -- Pharma Matters Report /slideshow/the-ones-to-watch-oct-dec-2009-pharma-matters-report/9364790 theonestowatchoct-dec-2009-pharmamattersreport-110921144426-phpapp02
]]>
]]> Wed, 21 Sep 2011 14:44:23 GMT /slideshow/the-ones-to-watch-oct-dec-2009-pharma-matters-report/9364790 pharmaknowledge@slideshare.net(pharmaknowledge) The Ones to Watch, Oct. - Dec. 2009 -- Pharma Matters Report pharmaknowledge <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/theonestowatchoct-dec-2009-pharmamattersreport-110921144426-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
The Ones to Watch, Oct. - Dec. 2009 -- Pharma Matters Report from Thomson Reuters
]]> 671 5 https://cdn.slidesharecdn.com/ss_thumbnails/theonestowatchoct-dec-2009-pharmamattersreport-110921144426-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 The Five Myths of Generic Competition /slideshow/the-five-myths-of-generic-competition/9364595 thefivemythsofgenericcompetition-110921142040-phpapp01
]]>
]]> Wed, 21 Sep 2011 14:20:38 GMT /slideshow/the-five-myths-of-generic-competition/9364595 pharmaknowledge@slideshare.net(pharmaknowledge) The Five Myths of Generic Competition pharmaknowledge <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/thefivemythsofgenericcompetition-110921142040-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
The Five Myths of Generic Competition from Thomson Reuters
]]> 1287 4 https://cdn.slidesharecdn.com/ss_thumbnails/thefivemythsofgenericcompetition-110921142040-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Pharmaceutical Industry Terminology /slideshow/pharmaceutical-industry-terminology/9347730 pharmaceutical-industry-terminology-110920152215-phpapp02
]]>
]]> Tue, 20 Sep 2011 15:22:14 GMT /slideshow/pharmaceutical-industry-terminology/9347730 pharmaknowledge@slideshare.net(pharmaknowledge) Pharmaceutical Industry Terminology pharmaknowledge <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/pharmaceutical-industry-terminology-110920152215-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Pharmaceutical Industry Terminology from Thomson Reuters
]]> 4036 9 https://cdn.slidesharecdn.com/ss_thumbnails/pharmaceutical-industry-terminology-110920152215-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 The Ones to Watch, Oct. - Dec. 2010 -- Pharma Matters Report /slideshow/the-ones-to-watch-oct-dec-2010-pharma-matters-report/9274717 theonestowatchoct-dec-2010pharmamattersreport-110915165728-phpapp02
]]>
]]> Thu, 15 Sep 2011 16:57:26 GMT /slideshow/the-ones-to-watch-oct-dec-2010-pharma-matters-report/9274717 pharmaknowledge@slideshare.net(pharmaknowledge) The Ones to Watch, Oct. - Dec. 2010 -- Pharma Matters Report pharmaknowledge <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/theonestowatchoct-dec-2010pharmamattersreport-110915165728-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
The Ones to Watch, Oct. - Dec. 2010 -- Pharma Matters Report from Thomson Reuters
]]> 1092 9 https://cdn.slidesharecdn.com/ss_thumbnails/theonestowatchoct-dec-2010pharmamattersreport-110915165728-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 The Ones to Watch, Jan. - Mar. 2010 -- Pharma Matters Report /slideshow/the-ones-to-watch-jan-mar-2010-pharma-matters-report/9274713 theonestowatchjan-mar-2010pharmamattersreport-110915165653-phpapp01
]]>
]]> Thu, 15 Sep 2011 16:56:52 GMT /slideshow/the-ones-to-watch-jan-mar-2010-pharma-matters-report/9274713 pharmaknowledge@slideshare.net(pharmaknowledge) The Ones to Watch, Jan. - Mar. 2010 -- Pharma Matters Report pharmaknowledge <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/theonestowatchjan-mar-2010pharmamattersreport-110915165653-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
The Ones to Watch, Jan. - Mar. 2010 -- Pharma Matters Report from Thomson Reuters
]]> 587 3 https://cdn.slidesharecdn.com/ss_thumbnails/theonestowatchjan-mar-2010pharmamattersreport-110915165653-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds document White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 The Cutting Edge of Chemistry, Nov. 2010 -- Pharma Matters Report /slideshow/the-cutting-edge-of-chemistry-nov-2010-pharma-matters-report/9274711 thecuttingedgeofchemistrynov-2010-pharmamattersreport-110915165654-phpapp02
]]>
]]> Thu, 15 Sep 2011 16:56:50 GMT /slideshow/the-cutting-edge-of-chemistry-nov-2010-pharma-matters-report/9274711 pharmaknowledge@slideshare.net(pharmaknowledge) The Cutting Edge of Chemistry, Nov. 2010 -- Pharma Matters Report pharmaknowledge <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/thecuttingedgeofchemistrynov-2010-pharmamattersreport-110915165654-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
The Cutting Edge of Chemistry, Nov. 2010 -- Pharma Matters Report from Thomson Reuters
]]> 592 7 https://cdn.slidesharecdn.com/ss_thumbnails/thecuttingedgeofchemistrynov-2010-pharmamattersreport-110915165654-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 The Cutting Edge of Chemistry, Jan. - Mar. 2010 -- Pharma Matters Report /slideshow/the-cutting-edge-of-chemistry-jan-mar-2010-pharma-matters-report/9274710 thecuttingedgeofchemistryjan-mar-2010-pharmamattersreport-110915165652-phpapp02
]]>
]]> Thu, 15 Sep 2011 16:56:50 GMT /slideshow/the-cutting-edge-of-chemistry-jan-mar-2010-pharma-matters-report/9274710 pharmaknowledge@slideshare.net(pharmaknowledge) The Cutting Edge of Chemistry, Jan. - Mar. 2010 -- Pharma Matters Report pharmaknowledge <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/thecuttingedgeofchemistryjan-mar-2010-pharmamattersreport-110915165652-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
The Cutting Edge of Chemistry, Jan. - Mar. 2010 -- Pharma Matters Report from Thomson Reuters
]]> 564 6 https://cdn.slidesharecdn.com/ss_thumbnails/thecuttingedgeofchemistryjan-mar-2010-pharmamattersreport-110915165652-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Spotlight On... Obesity, Dec. 2010 -- Pharma Matters Report /pharmaknowledge/spotlight-on-obesity-dec-2010-pharma-matters-report spotlighton-obesitydec-2010-pharmamattersreport-110915165648-phpapp02
]]>
]]> Thu, 15 Sep 2011 16:56:48 GMT /pharmaknowledge/spotlight-on-obesity-dec-2010-pharma-matters-report pharmaknowledge@slideshare.net(pharmaknowledge) Spotlight On... Obesity, Dec. 2010 -- Pharma Matters Report pharmaknowledge <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/spotlighton-obesitydec-2010-pharmamattersreport-110915165648-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Spotlight On... Obesity, Dec. 2010 -- Pharma Matters Report from Thomson Reuters
]]> 823 12 https://cdn.slidesharecdn.com/ss_thumbnails/spotlighton-obesitydec-2010-pharmamattersreport-110915165648-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Movers and Shakers, Oct. - Dec. 2009 -- Pharma Matters Report /slideshow/movers-and-shakers-oct-dec-2009-pharma-matters-report/9274706 moversandshakersoct-dec-2009-pharmamattersreport-110915165647-phpapp02
In this quarterly report, we look at a few of the companies beginning to make their marks on the US generics market either with their fi nished dose products or active ingredients, and analyze trends and statistics relating to the market as a whole.]]>
In this quarterly report, we look at a few of the companies beginning to make their marks on the US generics market either with their fi nished dose products or active ingredients, and analyze trends and statistics relating to the market as a whole.]]> Thu, 15 Sep 2011 16:56:44 GMT /slideshow/movers-and-shakers-oct-dec-2009-pharma-matters-report/9274706 pharmaknowledge@slideshare.net(pharmaknowledge) Movers and Shakers, Oct. - Dec. 2009 -- Pharma Matters Report pharmaknowledge In this quarterly report, we look at a few of the companies beginning to make their marks on the US generics market either with their fi nished dose products or active ingredients, and analyze trends and statistics relating to the market as a whole. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/moversandshakersoct-dec-2009-pharmamattersreport-110915165647-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> In this quarterly report, we look at a few of the companies beginning to make their marks on the US generics market either with their fi nished dose products or active ingredients, and analyze trends and statistics relating to the market as a whole.
Movers and Shakers, Oct. - Dec. 2009 -- Pharma Matters Report from Thomson Reuters
]]> 874 5 https://cdn.slidesharecdn.com/ss_thumbnails/moversandshakersoct-dec-2009-pharmamattersreport-110915165647-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Movers and Shakers, Jul. - Sep. 2010 -- Pharma Matters Report /slideshow/movers-and-shakers-jul-sep-2010-pharma-matters-report/9274704 moversandshakersjul-sep-2010-pharmamattersreport-110915165644-phpapp01
In this quarterly report, we look at a few of the companies beginning to make their marks on the US generics market either with their fi nished dose products or active ingredients, and analyze trends and statistics relating to the market as a whole.]]>
In this quarterly report, we look at a few of the companies beginning to make their marks on the US generics market either with their fi nished dose products or active ingredients, and analyze trends and statistics relating to the market as a whole.]]> Thu, 15 Sep 2011 16:56:42 GMT /slideshow/movers-and-shakers-jul-sep-2010-pharma-matters-report/9274704 pharmaknowledge@slideshare.net(pharmaknowledge) Movers and Shakers, Jul. - Sep. 2010 -- Pharma Matters Report pharmaknowledge In this quarterly report, we look at a few of the companies beginning to make their marks on the US generics market either with their fi nished dose products or active ingredients, and analyze trends and statistics relating to the market as a whole. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/moversandshakersjul-sep-2010-pharmamattersreport-110915165644-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> In this quarterly report, we look at a few of the companies beginning to make their marks on the US generics market either with their fi nished dose products or active ingredients, and analyze trends and statistics relating to the market as a whole.
Movers and Shakers, Jul. - Sep. 2010 -- Pharma Matters Report from Thomson Reuters
]]> 725 5 https://cdn.slidesharecdn.com/ss_thumbnails/moversandshakersjul-sep-2010-pharmamattersreport-110915165644-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds document White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Movers and Shakers, Apr. - Jun. 2010 -- Pharma Matters Report /slideshow/movers-and-shakers-apr-jun-2010-pharma-matters-report/9274703 moversandshakersapr-jun-2010-pharmamattersreport-110915165642-phpapp02
In this quarterly report, we look at a few of the companies beginning to make their marks on the US generics market either with their fi nished dose products or active ingredients, and analyze trends and statistics relating to the market as a whole.]]>
In this quarterly report, we look at a few of the companies beginning to make their marks on the US generics market either with their fi nished dose products or active ingredients, and analyze trends and statistics relating to the market as a whole.]]> Thu, 15 Sep 2011 16:56:41 GMT /slideshow/movers-and-shakers-apr-jun-2010-pharma-matters-report/9274703 pharmaknowledge@slideshare.net(pharmaknowledge) Movers and Shakers, Apr. - Jun. 2010 -- Pharma Matters Report pharmaknowledge In this quarterly report, we look at a few of the companies beginning to make their marks on the US generics market either with their fi nished dose products or active ingredients, and analyze trends and statistics relating to the market as a whole. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/moversandshakersapr-jun-2010-pharmamattersreport-110915165642-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> In this quarterly report, we look at a few of the companies beginning to make their marks on the US generics market either with their fi nished dose products or active ingredients, and analyze trends and statistics relating to the market as a whole.
Movers and Shakers, Apr. - Jun. 2010 -- Pharma Matters Report from Thomson Reuters
]]> 689 2 https://cdn.slidesharecdn.com/ss_thumbnails/moversandshakersapr-jun-2010-pharmamattersreport-110915165642-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 The Ones to Watch, Jul. - Sep. 2010 -- Pharma Matters Report /slideshow/the-ones-to-watch-jul-sep-2010-pharma-matters-report/9274702 theonestowatchjul-sep-2010pharmamattersreport-110915165643-phpapp01
]]>
]]> Thu, 15 Sep 2011 16:56:40 GMT /slideshow/the-ones-to-watch-jul-sep-2010-pharma-matters-report/9274702 pharmaknowledge@slideshare.net(pharmaknowledge) The Ones to Watch, Jul. - Sep. 2010 -- Pharma Matters Report pharmaknowledge <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/theonestowatchjul-sep-2010pharmamattersreport-110915165643-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
The Ones to Watch, Jul. - Sep. 2010 -- Pharma Matters Report from Thomson Reuters
]]> 488 6 https://cdn.slidesharecdn.com/ss_thumbnails/theonestowatchjul-sep-2010pharmamattersreport-110915165643-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds document White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 The Cutting Edge of Chemistry, Apr. - Jun. 2010 -- Pharma Matters Report /pharmaknowledge/the-cutting-edge-of-chemistry-apr-jun-2010-pharma-matters-report thecuttingedgeofchemistryapr-jun-2010-pharmamattersreport-110915160755-phpapp02
]]>
]]> Thu, 15 Sep 2011 16:07:53 GMT /pharmaknowledge/the-cutting-edge-of-chemistry-apr-jun-2010-pharma-matters-report pharmaknowledge@slideshare.net(pharmaknowledge) The Cutting Edge of Chemistry, Apr. - Jun. 2010 -- Pharma Matters Report pharmaknowledge <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/thecuttingedgeofchemistryapr-jun-2010-pharmamattersreport-110915160755-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
The Cutting Edge of Chemistry, Apr. - Jun. 2010 -- Pharma Matters Report from Thomson Reuters
]]> 618 3 https://cdn.slidesharecdn.com/ss_thumbnails/thecuttingedgeofchemistryapr-jun-2010-pharmamattersreport-110915160755-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://cdn.slidesharecdn.com/profile-photo-pharmaknowledge-48x48.jpg?cb=1523093119 Thought Leadership from Life Sciences at Thomson Reuters thomsonreuters.com/products_services/science/pharmaceutical_hub/ https://cdn.slidesharecdn.com/ss_thumbnails/spotlightoncwpenissue03-120507162836-phpapp01-thumbnail.jpg?width=320&height=320&fit=bounds pharmaknowledge/spotlight-on-cwpenissue03 Spotlight On... Anti-T... https://cdn.slidesharecdn.com/ss_thumbnails/theonestowatchoct-dec-2009-pharmamattersreport-110921144426-phpapp02-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/the-ones-to-watch-oct-dec-2009-pharma-matters-report/9364790 The Ones to Watch, Oct... https://cdn.slidesharecdn.com/ss_thumbnails/thefivemythsofgenericcompetition-110921142040-phpapp01-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/the-five-myths-of-generic-competition/9364595 The Five Myths of Gene...